How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07%

Wall Street analysts’ average price target implies 38.1% upside for The Oncology Institute (TOI). The article also notes a favorable trend in earnings estimate revisions, which could support further stock appreciation. Overall, this is a constructive but non-catalytic analyst-driven update rather than a fundamental event.

Analysis

Wall Street analysts’ average price target implies 38.1% upside for The Oncology Institute (TOI). The article also notes a favorable trend in earnings estimate revisions, which could support further stock appreciation. Overall, this is a constructive but non-catalytic analyst-driven update rather than a fundamental event.